BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29042764)

  • 1. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
    Miravitlles M; Worth H; Soler Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    Respir Res; 2014 Oct; 15(1):122. PubMed ID: 25331383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.
    Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
    Respir Res; 2012 Sep; 13(1):85. PubMed ID: 23006638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
    Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    NPJ Prim Care Respir Med; 2015 Nov; 25():15063. PubMed ID: 26538368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.
    Yohannes AM; Casaburi R; Dryden S; Hanania NA
    Respir Med; 2024 Jun; 227():107633. PubMed ID: 38631527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management Reality of Female Patients with COPD: A Multicenter Cross-Sectional CAP Study in Japan.
    Yamamoto T; Oishi K; Ohata S; Murata Y; Yamaji Y; Asami-Noyama M; Edakuni N; Kakugawa T; Hirano T; Matsunaga K
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1123-1130. PubMed ID: 38803411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical inactivity in COPD and increased patient perception of dyspnea.
    Katajisto M; Kupiainen H; Rantanen P; Lindqvist A; Kilpeläinen M; Tikkanen H; Laitinen T
    Int J Chron Obstruct Pulmon Dis; 2012; 7():743-55. PubMed ID: 23152679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
    Flynn RWV; MacDonald TM; Chalmers JD; Schembri S
    Respir Res; 2018 Dec; 19(1):249. PubMed ID: 30541559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
    Han MK; Muellerova H; Curran-Everett D; Dransfield MT; Washko GR; Regan EA; Bowler RP; Beaty TH; Hokanson JE; Lynch DA; Jones PW; Anzueto A; Martinez FJ; Crapo JD; Silverman EK; Make BJ
    Lancet Respir Med; 2013 Mar; 1(1):43-50. PubMed ID: 24321803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials.
    Leidy NK; Murray LT; Monz BU; Nelsen L; Goldman M; Jones PW; Dansie EJ; Sethi S
    Respir Res; 2014 Oct; 15(1):124. PubMed ID: 25287629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
    Kulich K; Keininger DL; Tiplady B; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Impact of Depressive Symptoms and FEV
    O'Toole J; Woo H; Putcha N; Cooper CB; Woodruff P; Kanner RE; Paine R; Bowler RP; Comellas A; Hoth KF; Krishnan JA; Han M; Dransfield M; Iyer AS; Couper D; Peters SP; Criner G; Kim V; Barr RG; Martinez FJ; Hansel NN; Eakin MN;
    Ann Am Thorac Soc; 2022 Feb; 19(2):171-178. PubMed ID: 34410883
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between lung function and exacerbation frequency in patients with COPD.
    Hoogendoorn M; Feenstra TL; Hoogenveen RT; Al M; Mölken MR
    Int J Chron Obstruct Pulmon Dis; 2010 Dec; 5():435-44. PubMed ID: 21191438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of chronic obstructive pulmonary disease in young-old adults' life-space mobility.
    Garcia IFF; Tiuganji CT; Simões MDSMP; Santoro IL; Lunardi AC
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2777-2785. PubMed ID: 29026295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial.
    O'Donnell DE; Maltais F; Porszasz J; Webb KA; Albers FC; Deng Q; Iqbal A; Paden HA; Casaburi R;
    PLoS One; 2014; 9(5):e96574. PubMed ID: 24788342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum microbiology predicts health status in COPD.
    Braeken DC; Houben-Wilke S; Smid DE; Rohde GG; Drijkoningen JJ; Wouters EF; Spruit MA; Franssen FM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2741-2748. PubMed ID: 27853361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for developing hypoxic respiratory failure in COPD.
    Sundh J; Ekström M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2095-2100. PubMed ID: 28790812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship of Bone Mineral Density in Men with Chronic Obstructive Pulmonary Disease Classified According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Combined Chronic Obstructive Pulmonary Disease (COPD) Assessment System.
    Sakurai-Iesato Y; Kawata N; Tada Y; Iesato K; Matsuura Y; Yahaba M; Suzuki T; Ikari J; Yanagawa N; Kasahara Y; West J; Tatsumi K
    Intern Med; 2017; 56(14):1781-1790. PubMed ID: 28717072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of systemic immune-inflammation index with lung function, risk of COPD and COPD severity: A population-based study.
    Song YD; Bai XM; Ma J
    PLoS One; 2024; 19(6):e0303286. PubMed ID: 38875233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.